Disease

Cancer

Connection between angiogenesis and drug resistance in breast cancer

LABline

Dec. 12, 2024

New cancer study.

Disease

WHO urges countries to reinvigorate global malaria efforts

LABline

Dec. 12, 2024

STIs/STDs

Worldwide genital herpes infection rates

LABline

Dec. 11, 2024

Colorized transmission electron micrograph of two particles of the virus that causes mpox, cultivated and purified from cell culture. NIAID.

Disease

Tecovirimat safe but does not aid mpox symptoms

LABline

Dec. 11, 2024

H5N1 avian influenza particles (rod-shaped; orange) NIAID and CDC.

Flu

Study finds mutation in H5N1 influenza surface protein could aid human infection

LABline

Dec. 10, 2024

Disease

New potential therapeutic targets could prevent end stage kidney failure

LABline

Dec. 10, 2024

Cancer

In five cancer types, prevention and screening have been major contributors to saving lives

LABline

Dec. 6, 2024

NIH modeling study looked at the individual and combined impacts of cancer prevention, screening, and treatment.

Disease

Next steps taken to increase access to sickle cell disease treatments

LABline

Dec. 5, 2024

In the United States, more than 100,000 people live with sickle cell disease, with approximately 50% to 60% enrolled in Medicaid.

Disease

Long COVID-19 is costing Americans money

LABline

Dec. 5, 2024

Lower income groups more likely to experience food insecurity, inability to pay bills due to condition.

Cancer

More cancers are being treated with personalized therapies before surgery

LABline

Dec. 4, 2024

New treatment options and early detection are helping improve cancer care, according to the first-ever annual report from the National Cancer Database of the American College ...

Disease

CHIP is an independent risk factor for ICI myocarditis

LABline

Dec. 4, 2024

Yale study.

Cancer

Enzyme identified as new therapeutic target for “cold” tumors

LABline

Dec. 4, 2024

Drugs that suppress UBA1 could make immune checkpoint blocking immunotherapy effective for patients with prostate cancer and other “cold” tumors.

STIs/STDs

Testing for sexually transmitted infections: MLO’s December CE

LABline

Dec. 3, 2024

Read this online exclusive article, take the test, and earn P.A.C.E. credit.

Disease

A cause of hyperinflammatory response in lethal COVID-19 identified

LABline

Dec. 3, 2024

Part of the COVID-19 International Research Team.

HIV

Twice-yearly lenacapavir for PrEP reduces HIV infections by 96%

LABline

Dec. 3, 2024

HIV pre-exposure prophylaxis (PrEP) has emerged as a crucial tool for fighting the global HIV epidemic, but researchers say daily pill regimens remain an obstacle to treatment...